Munsch Frederick, an officer at Bausch & Lomb Corp, has filed to sell 112,015 shares of the company, valued at approximately $2.29 million. This transaction is noteworthy as it reflects both personal financial strategies and the ongoing market dynamics within the ophthalmic goods sector.

Background

Bausch & Lomb Corp is a prominent player in the ophthalmic goods industry, known for its wide range of eye care products. The company operates under the SIC code for ophthalmic goods. Munsch Frederick's recent filing adds to the company's recent activity, which includes multiple filings in the past few months.

What the Filing Says

The filing, submitted on October 29, 2026, indicates that Munsch Frederick exercised stock options to acquire the shares before selling them. The document states, "Munsch Frederick plans to sell 112,015 shares of Bausch & Lomb Corp." This sale is set to take place on the same date as the filing.

Impact

This transaction may affect various stakeholders, including investors and market analysts, who observe insider trading activities as indicators of company health and management confidence. The sale of shares by an officer could signal changes in personal financial strategies, which may influence investor sentiment.

What's Next

The filing does not say what happens next.